Insulet Corp. (PODD) Misses Q1 EPS by 1c, Offers Q2, FY Rev. Guiance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Insulet Reports First Quarter 2015 Financial Results
April 30, 2015 4:01 PM EDTBILLERICA, MA -- (Marketwired) -- 04/30/15 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced financial results for the three months ended March 31, 2015.
First Quarter Highlights and Recent Developments:
First quarter financial results: U.S. OmniPod revenue in-line with Company's expectations. Drug Delivery and International shipments planned for the first quarter now expected to be realized during remainder of 2015. Strengthened senior leadership team with appointment of highly-experienced Chief Financial Officer. Previously announced: First... More